NCT06512987

Brief Summary

This study investigates the effectiveness of a technology-driven, interactive ICU diary in reducing psychological distress, specifically anxiety, depression, and stress, in ICU patients. A single-blind, parallel-group randomized controlled trial will include 56 conscious ICU patients. The primary outcome measures are the Depression, Anxiety, and Stress Scale-21 (DASS-21) and the EuroQol instrument (EQ-5D), assessed at ICU admission, discharge, and one month post-discharge.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 22, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

August 14, 2025

Status Verified

July 1, 2024

Enrollment Period

8 months

First QC Date

July 10, 2024

Last Update Submit

August 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Psychological Distress Levels (DASS-21)

    The primary outcome will be the psychological distress levels measured by the Depression, Anxiety, and Stress Scale-21 (DASS-21). This scale assesses anxiety, depression, and stress in ICU patients through 21 items, each rated from 0 ("Did not apply to me at all - Never") to 3 ("Applied to me very much, or most of the time - Almost always"). The total score for each subscale (DASS-21-Depression, DASS-21-Anxiety, and DASS-21-Stress) ranges from 0 to 21, with higher scores indicating greater emotional distress. The cutoff scores for DASS-21-Depression, DASS-21-Anxiety, and DASS-21-Stress are \>9, \>7, and \>14, respectively.

    7 days after admission and one month post-discharge.

Secondary Outcomes (1)

  • Quality of Life (EQ-5D)

    7 days after admission and one month post-discharge.

Study Arms (2)

Interactive ICU Diary Group

EXPERIMENTAL

Patients in this group will use a technology-driven, interactive ICU diary from the first day of ICU admission until discharge. Through the diary platform, patients can share their feelings and needs, while family members can send supportive messages, pictures, and videos. Healthcare providers will use the platform to connect with families and monitor patient conditions. The goal is to reduce psychological distress, specifically anxiety, depression, and stress, during the ICU stay.

Other: technology-driven, interactive ICU diary

routine care

NO INTERVENTION

Patients in this group will receive standard ICU care without the use of the interactive ICU diary.

Interventions

Through the diary platform, patients can share their feelings and needs, while family members can send supportive messages, pictures, and videos. Healthcare providers will use the platform to connect with families and monitor patient conditions.

Interactive ICU Diary Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Clear consciousness and able to communicate in Mandarin, Taiwanese, or Hakka
  • Expected ICU stay of at least 72 hours
  • Ability to operate a smart device and use social media applications

You may not qualify if:

  • Presence of delirium before joining the study (Intensive Care Delirium Screening Checklist score ≥ 4)
  • Physical, auditory, or visual impairments preventing the use of smart devices History of epilepsy, cognitive impairments (e.g., hepatic encephalopathy, dementia), or psychiatric disorders
  • Richmond Agitation-Sedation Scale score not between +1 and -1 (indicating excessive sedation or agitation)
  • Acute Physiology and Chronic Health Evaluation Score (APACHE-II) \> 25 within the first 24 hours of ICU admission (indicating \> 50% mortality rate)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Medical University Hospital

Taipei, 110, Taiwan

Location

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Hsiao-Yean Chiu

    Taipei Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2024

First Posted

July 22, 2024

Study Start

September 1, 2024

Primary Completion

April 30, 2025

Study Completion

May 31, 2025

Last Updated

August 14, 2025

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations